Sana Biotechnology, Inc. (SANA) Operating cash flow 2019–2025
Sana Biotechnology, Inc. (SANA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$143.8MFY2025 · since FY2019: -$85.5M → -$143.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$143.8M | +35.5% |
| FY2024 | -$223.2M | +12.0% |
| FY2023 | -$253.6M | +12.6% |
| FY2022 | -$290.1M | -15.5% |
| FY2021 | -$251.1M | -81.9% |
| FY2020 | -$138.0M | -61.3% |
| FY2019 | -$85.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SANA financial trends
SANA RevenueSANA Net incomeSANA Net marginSANA Gross profitSANA Gross marginSANA Operating incomeSANA Operating marginSANA Free cash flowSANA Capital expendituresSANA Return on equitySANA Stock buybacksSANA Dividends paidSANA Total assetsSANA Total liabilitiesSANA Shareholders’ equitySANA overview →